John F. Neylan - 18 May 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Senior Vice President and Chief Medical Officer
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan
Issuer symbol
ELTX
Transactions as of
18 May 2021
Net transactions value
-$5,049
Form type
4
Filing time
19 May 2021, 17:10:44 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale $5,049 -363 -0.95% $13.91 37,729 18 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.

Remarks:

Senior Vice President and Chief Medical Officer